Immunology

Antibodies for Immunology Researchbioxcell.com

Antibodies for Immunology Research
α-mouse 4-1BB (BP0169)
CD4+ T cells

α-mouse CD4 (BP0003-1)

α-mouse CD8α (BP0061)

α-mouse CD8α (BP0117)

Control

Relative Cell Number

LOB12.3

CD4 (55 kDa)
CD8α (35 kDa)

Purified CD4

Log Fluorescence Intensity

CD8α (35 kDa)

Purified CD8α

Purified CD8α

IsotypeControl

Antigen

Reactivity

Application

Clone

Catalog
Number

2C TCR

mouse

IF, FC

1B2

BE00694-1BB (CD137)

mousein vivo activation of 4-1BB

LOB12.3

BP0169BP00894-1BB (CD137)

mousein vivo and in vitro 4-1BB stimulation

3H3

BP0239BP00894-1BB (CD137)

mousein vitro 4-1BB blockade, FC

17B5

BE0296

BE00874-1BBL (CD137L)

mouse

in vivo 4-1BBL blockade

TKS-1

BE0110BE0089

B220

mouse

in vivo B cell depletion, in vitro B cell negative selection

RA3.3A1/6.1

BE0067BE0094B7-1 (CD80)

mousein vivo B7-1 blockade, Affinity chromatography

1G10

BE0134BE0089BTLA (CD272)

mousein vivo BTLA stimulation, in vivo BTLA blockade

6A6BE0132

BE0091

BTLA (CD272)

mousein vivo and in vitro stimulation of BTLA, FC

PK18.6

BE0153BE0088

BTLA (CD272)

mousein vivo BTLA blockade, in vitro T cell stimulation/activation, FC

PJ196

BE0196

BE0083

BTLA (CD272)

mousein vivo BTLA+ B cell and CD4 T cell depletion, FC

6F7

BE0304BE0083c-Kit (CD117)

mouse

FC, IF, IHC

2B8

BE0280BE0090c-Kit (CD117)

mousein vivo mast cell depletion, in vivo c-Kit+ cell depletion, in vitro c-Kit neutralization, IP, FC

ACK2

BE0293BE0090

CCL2 (MCP-1)

mouse/human/rat

in vivo CCL2 neutralization, IHC-F

2H5

BE0185BE0091

CCR3 (CD193)

mousein vivo eosinophil depletion

6S2-19-4

BE0316

BE0090

CD1a

human

in vitro CD1a blockade, FC

OKT-6

BE0211

BE0083CD1d (CD1.1)

mouse

in vivo CD1d neutralization

19G11

BE0000BE0088CD1d (CD1.1)

mouse

in vivo CD1d blockade, iNKT cell neutralization, FC

20H2 (HB323)

BE0179BE0088CD3

humanin vivo T cell depletion in humanized mice, in vitro T cell stimulation/activation, ex vivo T cell inhibition for xenographs, FC

OKT-3

BE0001-2

BE0085CD3

mousein vitro T cell stimulation/activation

17A2

BE0002

BE0090CD3

human

in vivo T cell depletion in humanized mice, ex vivo T cell inhibition for xenographs, FC

UCHT1 (Leu-4) (T3)

BE0231

BE0083

CD3ɛ

mouse

in vivo T cell depletion, in vitro T cell stimulation/activation, IF, FC

145-2C11BP0001-1

BP0091

CD3ɛ

mouse

in vitro T cell negative selection, in vitro T cell stimulation/activation, IF

KT3

BE0261

BE0089CD3ɛ F(ab')2 fragment

mouse

in vivo T cell depletion

145-2C11 f(ab')2 Fragments

BE0001-1FAB

BE0091-FAB

CD4

mouse

in vivo CD4+ T cell depletion, FC

GK1.5

BP0003-1

BP0090CD4

human

in vitro T cell stimulation/activation, in vivo CD4+ T cell depletion in humanized mice, FC, IP

OKT-4BE0003-2BE0086CD4

mousein vivo blockade of CD4+ T-cell responses, WB

YTS 177BE0003-3BE0089CD4

mousein vivo CD4+ T cell depletion

YTS 191

BE0119BE0090CD4

human

in vitro CD4 blockade, in vitro blocking of CD4+ T cell activation, IF, IHC-F, FC

RPA-T4

BE0288BE0083

CD4

rat

in vivo CD4+ T cell depletion, FC

OX-38

BE0308BE0085CD8 (Lyt 2.1)

mouse

in vivo CD8+ T cell depletion, FC

116-13.1 (HB129)

BE0118BE0085

CD8α

mouse

in vivo CD8+ T cell depletion, IF, FC

53-6.7BP0004-1

BP0089

CD8α

human

in vivo CD8+ T cell depletion in humanized mice

OKT-8

BE0004-2BE0085

CD8α

mouse

in vivo CD8+ T cell depletion

2.43

BP0061BP0090

CD8α

mouse

in vivo CD8+ T cell depletion

YTS 169.4

BE0117BP0090CD8β (Lyt 3.2)

mouse

in vivo CD8+ T cell depletion, in vitro CD8 blockade, IF

53-5.8BE0223BE0088CD11bmouse/humanin vivo CD11b neutralization, ILC2 cell purification, FC

M1/70

BE0007BE0090CD16/CD32

mousein vitro and in vivo Fc receptor blocking

2.4G2

BE0307BE0090

CD19

mouse

in vivo B cell depletion, in vivo CD19 neutralization, in vitro B cell negative selection, FC

1D3

BE0150BE0089

CD19

human

Functional assays, Chimeric antigen receptor construction, FC, IF

4G7

BE0281

BE0083

CD20

mouse

in vivo B cell depletion, WB

MB20-11

BP0356

BP0366

CD22

mouse

in vivo B cell depletion in combination with anti-CD19 (clone 1D3) and anti-rat κ Light Chain (clone MAR 18.5), FC, IP

Cy34.1BE0011

BE0083

CD24

mouse

in vivo administration, IHC-F, IHC-P, IF, FC

M1/69

BE0360BE0090

CD25 (IL-2Rα)

mousein vivo regulatory T cell depletion, FC

PC-61.5.3

BP0012BP0088

CD25 (IL-2Rα)

human

IP, IF

7G7B6BE0014BE0085

CD27

mouse

in vivo CD27 stimulation, in vitro CD27 stimulation, IP, FC

RM27-3E5

BE0348BE0089

CD28

mouse

in vitro T cell stimulation/activation, in vivo CD28 blockade

37.51

BE0015-1

BE0087

CD28

mouse

in vitro T cell stimulation/activation

PV-1

BE0015-5BE0091

CD28

mouse

in vivo and in vitro T cell stimulation/activation

D665

BE0328BE0083

CD32 (FcγRIIA)

human

in vivo FcγRIIA blockade in humanized mice, in vitro FcγRIIA blockade, ELISA, FC

IV.3

BE0224BE0086

CD38

mouse

in vivo and in vitro CD38 stimulation, in vitro B cell activation, IF

NIMR5

BE0317

BE0089

CD40

mouse

in vivo CD40 activation, in vitro B cell stimulation/activation

FGK4.5/FGK45

BE0016-2

BP0016-2

IF Immunofluorescence | IHC-F Immunohistochemistry (frozen) | IHC-P Immunohistochemistry (paraffin) | WB Western blot | IP Immunoprecipitation

BE0083α-mouse CD40 (BP0016-2)

α-mouse CTLA-4 (BP0032)

CD4+ T cells

α-mouse CTLA-4 (BP0131)

α-mouse GITR (BP0063)

CD4+ T cells

Control

DTA-1

Relative Cell Number

CD40 (57 kDa)

CTLA-4 (30 kDa)

10

Purified CD40

1

10

2

10

3

10

4

Log Fluorescence Intensity

10

5

Control

Relative Cell Number

UC10-4F10-11

Purified CTLA-4

Log Fluorescence Intensity

IsotypeControl

Antigen

Reactivity

Application

Clone

Catalog
Number

CD40

human

in vitro B cell stimulation, in vitro macrophage stimulation, Functional assays, FC

G28.5

BE0189

CD40L (CD154)

mousein vivo and in vitro blocking of CD40/CD40L signaling

MR-1

BE0017-1

BP0091

CD40L (CD154)

human/monkey

in vivo and in vitro blocking of CD40/CD40L signaling, IP, FC

5C8

BE0292BE0085

CD45RBmouse

in vivo anti-CD45RB–mediated tolerance induction, in vivo pre-mNK cell depletion

MB23G2 (HB220)

BE0019BE0089CD45.2mouse

FC, IHC-F, in vitro CD45.2 blockade, in vivo CD45.2 blockade

104.2

BE0300BE0085

CD47

human

in vivo CD47 neutralization in human tumor xenograft models or humanized mice, in vitro CD47 neutralization, FC

B6H12BE0019-1

BE0083

CD47

human/mouse/rat in vivo and in vitro CD47 blockade, IF

MIAP410BE0283BP0083

CD47 (IAP)

mouse

in vivo CD47 blockade, in vitro CD47 blockade, IF

MIAP301

BE0270BE0089

CD48

mouse

in vivo and in vitro CD48 blockade

HM48-1

BE0147BE0091

CD54 (ICAM-1)

mousein vivo ICAM-1 neutralization

YN1/1.7.4

BE0020-1

BE0090

CD69

mouse

in vivo down-regulation of CD69 expression, Functional assays

CD69.2.2

BE0330BE0083

CD70

mouse

in vivo and in vitro CD70 blockade, FC

FR70

BE0022

BE0090CD71 (TfR1)

mousein vivo depletion of CD71+ cells

R17 217.1.3/TIB-219

BP0175BP0089CD71 (TfR1)

mousein vivo depletion of CD71+ cells, IF, IHC-F, WB

8D3

BP0329BP0089CD71 (TfR1)

rat/mouse

Targeted drug delivery to the brain, IHC-F, FC

OX-26

BE0331

BE0085

CD73

mouse

in vivo CD73 blockade

TY/23

BE0209BE0089CD80 (B7-1)

mouse

in vivo CD80 blockade, FC

16-10A1

BE0024BE0091

CD86 (B7-2)

mousein vivo CD86 blockade, FC

GL-1

BE0025

BE0089

CD96

mouse

in vivo and in vitro CD96 blocking, FC

3.3

BE0337

BE0088

CD103

mouse

in vivo CD103 neutralization, IF, FC

M290

BE0026

BE0089

CD106 (VCAM-1)

mousein vivo VCAM-1 neutralization, IF

M/K-2.7

BE0027

BE0088

CD122 (IL-2Rβ)mousein vitro NK cell negative selection, IP, FC

5H4

BE0272BE0089

CD122 (IL-2Rβ)mousein vivo NK cell depletion, in vitro IL-2R blockade, Functional assays, FC

TM-Beta 1

BE0298BE0090CD132 (common γ chain)mouse

in vivo γc blockade, Functional assays, IP, FC

3E12

BE0271

BE0090CD172a (SIRPα)mousein vivo and in vitro SIRPα blocking, WB, IP, FC

P84

BE0322BE0088CD200 (OX2)

mousein vivo and in vitro CD200 blockade, IHC-F, IF, FC

OX-90

BE0299BE0089CD209b (SIGN-R1)

mousein vivo SIGN-R1 blockade, IHC-F, WB, FC

22D1

BE0220BE0091

CD276 (B7-H3)

mousein vivo B7-H3 blockade, FC

MJ18

BE0124BE0088CD314 (NKG2D)

mouse

in vivo and in vitro NKG2D blockade, FC

CX5BE0334BE0088CD317 (BST2, PDCA-1)

mousein vivo pDC depletion, IF, FC

927

BE0311

BE0090

CLEC9A (CD370)

mousein vivo Ag targeting to CLEC9A+ DCs, WB, ELISA, IP, IF, FC

7H11

BE0305

BE0088

CSF1

mouse

in vitro CSF1 neutralization

5A1

BE0204BE0088

CSF1R (CD115)

mousein vivo macrophage depletion, in vivo monocyte depletion, in vitro CSF-R1 neutralization, FC

AFS98

BE0213BP0089CTLA-4 (CD152)

mousein vivo and in vitro CTLA-4 neutralization, FC

UC10-4F10-11BE0032BP0091CTLA-4 (CD152)

mousein vivo and in vitro CTLA-4 neutralization

9H10

BE0131BP0087CTLA-4 (CD152)

mousein vivo CTLA-4 neutralization

9D9

BE0164BP0086CTLA-4 (CD152)

humanin vitro CTLA-4 neutralization, FC

BN13

BE0190BE0085CXCL9 (MIG)

mouse

IF

MIG-2F5.5

BE0309BE0091CXCR3 (CD183)

mouse

in vivo CXCR3 neutralization, FC

CXCR3-173

BE0249BE0091

Delta-like protein 4 (DLL4)

mouse

in vivo DLL4 neutralization

HMD4-2

BE0127BE0091DR5 (CD262)

mousein vivo induction TRAIL-mediated apoptosis, in vitro induction TRAIL-mediated apoptosis

MD5-1

BE0161

BE0091

F4/80

mouse

in vivo Monocyte/Macrophage depletion, Functional assays, IHC-P, IHC-F, FC

CI:A3-1

BE0206

BE0090FasL (CD178)

mousein vivo and in vitro FasL blockade, Functional assay, IHC-P, FC

MFL3

BE0319BE0091

FGL-1

mouse

in vivo and in vitro FGL-1 blockade, FC, IHC-P

177R4

BE0332BE0083

Galectin-9

mouse

in vivo and in vitro Galectin-9 blockade

RG9-1

BE0218BE0090

GITR

mouse

in vivo GITR stimulation

DTA-1

BE0063BP0090

GM-CSFmousein vivo and in vitro GM-CSF neutralization, FC

MP1-22E9BE0259BE0089

ICOS

mouse

in vivo blocking of ICOS/ICOSL signaling, FC

7E.17G9

BE0059BE0090ICOSL (CD275)

mousein vivo ICOSL neutralization

HK5.3

BE0028BE0089IFNAR-1mouse

in vivo and in vitro IFNAR-1 blockade

MAR1-5A3

BE0241BP0083

IFNγ

mouse

in vivo and in vitro IFNγ neutralization

R4-6A2BE0054BE0088

IFNγ

mouse

in vivo and in vitro IFNγ neutralization, ELISPOT, FC

XMG1.2BE0055BP0088| FC Flow cytometry (requires flurochrome conjugation)

BE0083Your Trusted Supplier of in vivo MAbs.

α-mouse IFNγ (BP0055)

α-mouse IL-4 (BP0045)

α-mouse IL-12 p40 (BP0051)

α-mouse PD-1 (BP0146)

IL-12 p40
(50 kDa)

PD-1 (45 kDa)

IFNγ (21 kDa)
IL-4 (13kDa)
Purified IL-4

Purified IFNγ

Purified IL-12 p40

Purified PD-1

IsotypeControl

Antigen

Reactivity

Application

Clone

Catalog
Number

IFNγ

human

in vitro IFNγ neutralization

B133.5

BE0235

IFNγ

human

FC

B27

BE0245

BE0083

IFNγ

mouse

in vivo and in vitro IFNγ neutralization

H22

BE0312

BE0091IFNγR (CD119)

mouse

in vivo IFNγR neutralization

GR-20

BE0029BE0089IFNγRα (CD119)

mouse

WB, IP, FC

2E2

BE0287BE0091

IL-1 R (CD121a)mouse

in vitro IL-1 R blockade

JAMA-147

BE0256

BE0091

IL-1α

mouse

in vivo IL-1α neutralization

ALF-161BE0243BE0091IL-1βmouse/rat

in vivo and in vitro IL-1β neutralization, ELISA

B122

BE0246

BE0091

IL-2

mouse

in vivo and in vitro IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2), ELISPOT, FC

JES6-5H4

BE0042

BE0090

IL-2

mouse

in vivo IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2)

JES6-1A12

BE0043BE0089

IL-2

mouse

in vivo IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2)

S4B6-1

BE0043-1

BE0089

IL-3

mouse

in vivo and in vitro IL-3 neutralization, in vivo IL-3 receptor stimulation (as a complex with IL-3), ELISA, FC

MP2-8F8

BE0282BE0088

IL-4

mouse

in vitro and in vivo IL-4 neutralization, in vivo IL-4 receptor stimulation (as a complex with IL-4), FC

11B11

BP0045BP0088

IL-4

mouse

ELISA, ELISPOT, FC

BVD6-24G2

BE0199BE0088

IL-4

human

in vitro IL-4 neutralization, FC

MP4-25D2

BE0240BE0088IL-5mouse/humanin vivo IL-5 neutralization, in vivo eosinophil depletion

TRFK5

BE0198BE0088

IL-6

mouse

in vivo IL-6 neutralization, in vitro IL-6 neutralization

MP5-20F3

BE0046

BE0088

IL-6R

mouse

in vivo blocking of IL-6/IL-6R signaling, in vitro blocking of IL-6R signaling

15A7

BE0047BE0090IL-7

mouse/humanin vivo IL-7 neutralization, in vivo IL-7 receptor stimulation (as a complex with IL-7)

M25

BE0048BE0086

IL-7Rα (CD127)

mousein vivo blocking of IL-7Rα signaling, FC

A7R34

BE0065

BE0089

IL-9

mouse

in vivo IL-9 neutralization

9C1

BE0181

BE0085

IL-9

HUMAN

FC, ELISA

MH9A4

BE0327

BE0086

IL-10

mouse

in vivo IL-10 neutralization, in vitro IL-10 neutralization

JES5-2A5

BE0049BE0088

IL-10R (CD210)

mouse

in vivo blocking of IL-10/IL-10R signaling, in vitro blocking of IL-10R signaling, FC

1B1.3A

BP0050BP0088

IL-12

mouse

in vitro IL-12 neutralization

R1-5D9BE0052BE0089IL-12 p40

mouse

in vivo IL-12p40 neutralization, p40 affinity chromatography, IP, ELISA, FC, WB

C17.8

BP0051BP0089IL-12 p70

human

Functional assays, ELISA, FC

20C2

BE0234BE0088

IL-12 p75

mouse

in vivo IL-12p75 neutralization, ELISA

R2-9A5

BE0233BE0090

IL-15

mouse

in vivo and in vitro IL-15 neutralization

AIO.3

BE0315

BE0089IL-17Amousein vivo IL-17A neutralization

17F3

BP0173BP0083IL-17Fmousein vivo IL-17F neutralization

MM17F8F5.1A9

BE0303BE0083

IL-18

mouse

in vivo IL-18 neutralization

YIGIF74-1G7

BE0237

BE0089IL-21Rmouse

in vivo IL-21R blockade

4A9BE0258BE0089IL-23 (p19)

mousein vivo IL-2C1843p19 neutralization; WB

G23-8

BE0313BE0088

IL-27 p28

mouse

in vivo and in vitro IL-27 p28 neutralization, FC

MM27.7B1

BE0326

BE0085

Jagged2

mouse

in vivo Jagged 2 neutralization

HMJ2-1

BE0125BE0091

Kappa Immunoglobulin Light Chainrat

in vivo administration, FC

MAR 18.5

BE0122BE0085

Kappa Immunoglobulin Light Chain

mouse

IF

187.1 (HB58)

BE0176

BE0088KLRG-1

mouse/human

FC

2F1

BE0201

BE0087

LAG-3

mouse

in vivo and in vitro LAG-3 neutralization, FC

C9B7W

BP0174BP0088

Ly6C

mouse

in vivo macrophage depletion (in combination with clodronate liposomes), FC

Monts 1

BE0203BE0089

Ly6G

mouse

in vivo neutrophil depletion, in vivo MDSC depletion, IF, IHC-P, IHC-F, FC

1A8

BP0075-1

BP0089Ly6G/Ly6C (Gr-1)

mousein vivo neutrophil depletion, IHC-P, IHC-F, IF, FC

NIMP-R14

BE0320BE0090

Ly6G/Ly6C (Gr-1)

mousein vivo depletion of Gr-1+ myeloid cells, FC, IHC-P, IHC-F

RB6-8C5

BP0075BP0090

MDR-1 (CD243)

human/monkey

in vivo MDR-1 blocking/depletion in xenogeneic murine tumor models, in vitro MDR-1 blocking, IHC-P

UIC2

BE0340BE0085MHC Class I (H-2)

mouse

ex vivo blocking of MHC I–dependent interactions, IF, FC

M1/42.3.9.8

BE0077

BE0089MHC Class I (H-2Kb)mousein vivo administration, FC

AF6-88.5.5.3

BE0121

BE0085MHC Class I (H-2Kb)mousein vivo MHC II blockade, Functional assays, Purification of MHC peptide complexes, FC

Y-3

BE0172BE0086MHC Class I (H-2Kb) bound to SIINFEKL

mouse

in vivo blocking of Kb -SIINFEKL, Functional assays, FC

25-D1.16

BE0207

BE0083

MHC Class I (H-2Kd, H-2Dd)mousein vivo activation of APCs

34-1-2S

BE0180BE0085MHC Class I (H-2Kd)mousein vivo administration, Purification of MHC peptide complexes, FC

SF1.1.10 (HB159)

BE0104BE0085MHC Class I (H-2Kk, H-2Dk)

mousein vivo administration, FC

15-3-1S (HB13)

BE0158BE0085

IF Immunofluorescence | IHC-F Immunohistochemistry (frozen) | IHC-P Immunohistochemistry (paraffin) | WB Western blot | IP Immunoprecipitation

BE0083α-mouse TNFα (BP0058)

α-mouse VISTA (BP0310)
purity level

InVivoMab vs. InVivoPlus
InVivoMab

InVivoPlus< 2EU/mg< 1EU/mg

> 95%

> 95%

protein aggregates validated at ≤ 5%
azide and carrier protein free
VISTA (35 kDa)

endotoxin concentration
validated by immunoblot, FC, or ELISA
tested for murine pathogens

TNFα (17 kDa)
Purified CD40

Purified VISTA

available in bulk quantities

IsotypeControl

Antigen

Reactivity

Application

Clone

Catalog
NumberMHC Class I (H-2Kk, H-2Dk)

mouse

Functional assays, FC

16-1-2N (HB14)

BE0228MHC Class I (HLA-A, HLA-B, HLA-C)

human

Functional assays

W6/32

BE0079BE0085

MHC class II (HLA-DR)

human/monkey

in vitro blocking of MHC class II HLA-DR, HLA class II binding assay, in vitro MHC class II HLA-DR expressing cell negative selection, WB, FC

L243

BE0306

BE0085

MHC class II (I-A)

mousein vivo blockade of TCR stimulation, FC

Y-3P

BE0178BE0085MHC Class II (I-A/I-E)

mouse

in vivo MHC II blockade, Functional assays, FC

M5/114BE0108BE0090MHC II (I-Ak, I-Ar, I-Af, I-As,I-Ag7)mousein vitro MHC class II I-A blocking, in vitro MHC class II I-A expressing cell negative selection

10-3.6.2

BE0068BE0085MHC Class II (I-Ek/RT1-D)

mouse/rat

in vivo blocking of antigen presentation, FC

14-4-4S (HB32)

BE0167

BE0085MHC Class II (β chain)

mouse

WB

KL277

BE0140

N/A

NK1.1

mouse

in vivo NK cell depletion, FC

PK136

BP0036BP0085

NKG2A/C/E

mouse

in vivo and in vitro NKG2A blockade, IHC-F, FC

20D5

BE0321

BE0089NKG2AB6

mouse

FC

16A11

BE0339BE0086

NKG2D

mouse

in vivo NKG2D blockade

HMG2D

BE0111

BE0091

Nonclassical MHC Class I molecule Qa-1b

mouse

WB, IF

4C2.4A7.5H11

BE0165

BE0083

Notch4mousein vivo Notch4 blocking, in vitro Notch4 stimulation, FC

HMN4-14BE0129BE0091OX40 (CD134)

mousein vivo and in vitro OX40 activation

OX-86

BP0031BP0088OX40L (CD134L)

mouse

in vivo blocking of OX40/OX40L signaling, in vitro OX40L neutralization

RM134L

BE0033-1

BE0090PD-1 (CD279)

mousein vivo blocking of PD-1/PD-L signaling, in vitro PD-1 neutralization

J43

BP0033-2

BP0091

PD-1 (CD279)

mousein vivo blocking of PD-1/PD-L signaling

RMP1-14BP0146BP0089

PD-1 (CD279)

humanin vitro PD-1 neutralization, in vivo PD-1 blockade in humanized mice

J116

BE0188BE0083PD-1 (CD279)

humanin vivo PD-1 blockade in humanized mice, FC

J110

BE0193BE0083PD-1 (CD279)

mousein vivo blocking of PD-1/PD-L signaling, in vitro PD-1 neutralization, IHC-F, FC, WB

29F.1A12

BP0273BP0089PD-L1 (B7-H1)

mousein vivo PD-L1 blockade, IF, IHC-F, FC

10F.9G2

BP0101BP0090

PD-L1 (B7-H1)

humanin vitro PD-L1 blockade, Functional assays, IHC-F, FC

29E.2A3

BE0285

BE0086

PD-L2 (B7-DC)

mousein vivo PD-L2 blockade, in vitro PD-L2 blockade, IHC-F, FC

TY25

BE0112BE0089PSGL-1 (CD162)

mousein vivo PSGL-1 blockade, IHC-F

4RA10

BE0186

BE0088RANKL (CD254)

mousein vivo RANKL blockade

IK22/5

BE0191

BE0089Siglec-H

mousein vivo administration, FC

440c

BE0202

BE0090TCR Vγ1.1/Cr4

mouse

FC

2.11

BE0257BE0091

TCR γ/δmouse

in vivo TCR γ/δ neutralization, in vitro γ/δ T cell stimulation, in vitro γ/δ T cell purification, Functional assays, IP, FC

UC7-13D5

BE0070BE0091

TCRβ

mouse

in vivo T cell depletion

H57-597 (HB218)

BE0102

BE0091

Ter-119

mouse

in vivo administration, Functional assays, FC

TER-119

BE0183BE0090TGF-βmouse/human/rat/monkey/
hamster/canine/bovine

in vivo and in vitro TGF-β neutralization

1D11.16.8

BP0057BP0083Thy1 (CD90)

mousein vitro T cell depletion

M5/49.4.1

BE0076

BE0089Thy1.1 (CD90.1)

mouse

in vivo T cell depletion

19E12

BE0214BE0085Thy1.2 (CD90.2)

mouse

in vivo ILC depletion, in vivo T cell depletion

30H12BP0066BP0090

TIGIT

mouse

in vivo TIGIT stimulation, FC

1G9

BE0274BE0083

TIM-1 (CD365)

mousein vivo TIM-1 neutralization

RMT1-10BE0113BE0089

TIM-1 (CD365)

mousein vivo TIM-1 activation, in vitro T cell stimulation/activation, Functional assays, ELISA, FC

3B3

BE0289BE0089

TIM-1 (CD365)

mousein vivo and in vitro TIM-1 blockade

3D10BE0314BE0088

TIM-3 (CD366)

mousein vivo TIM-3 neutralization, in vitro TIM-3 blocking, FC

RMT3-23BP0115BP0089

TIM-3 (CD366)

mousein vivo TIM-3 neutralization, in vitro TIM-3 blocking, FC

B8.2C12BE0275

BE0088

TIM-4

mouse

in vivo and in vitro TIM-4 blockade, IF

RMT4-53

BE0171

BE0090

TIM-4

mouse

in vitro TIM-4 blocking, IF, FC

RMT 4-54

BE0225

BE0089

TIM-4

mouse

FC

F31-5G3

BE0344BE0088TL1A (TNFSF15)

mousein vivo TL1A neutralization, FC

5G4.2

BE0323BE0091

TNFR2 (CD120b)mouse

in vivo and in vitro TNFR2 blockade

TR75-54.7

BE0247BE0091

TNFα

mouse

in vivo and in vitro TNFα neutralization

XT3.11BP0058BP0088TNFαmouse/rat/rabbit

in vivo TNFα neutralization, FC

TN3-19.12

BE0244BE0091

VISTA

mouse

in vivo and in vitro blocking of VISTA signaling, FC

13F3

BP0310BP0091Vβ4 TCRmousein vivo administration, FC

KT4

BE0166

BE0090Vβ8 TCR

mouse

FC

F23.1

BE0182BE0085

Vγ2 TCRmousein vivo γδ T cell depletion, FC

UC3-10A6

BE0168BE0091| FC Flow cytometry (requires flurochrome conjugation)

BE0085Your Trusted Supplier of in vivo MAbs.

For over 25 years, scientists have trusted Bio X Cell as their go-to source for in vivo functional grade antibodies. Thisis reflected in over 15,000 peer-reviewed publications citing Bio X Cell products. We understand this responsibility
is of paramount importance and remain committed to producing antibodies of unparalleled quality and consistency,
enabling our partners around the globe to accelerate research and discoveries.

Bio X Cellbioxcell.com | 1.866.787.3444
customerservice@bioxcell.com
Conditions: For Research Use Only. Not for use in diagnostic or theraputic procedures. Not for resale.
Bio X Cell, Bio X Cell Logo and all other trademarks are the property of Bio X Cell. © 2022 Bio X Cell